Ibrutinib represents a novel class of immune modulating therapeutics that enhances the survival of activated T cells and reverses CLL cells mediated immunosuppression
LEUKEMIA & LYMPHOMA(2017)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
LEUKEMIA & LYMPHOMA(2017)